Free Shipping on Orders Over $149 — Lab-Tested 99%+ Purity — USA Shipped

VIP (Vasoactive Intestinal Peptide) 10mg - Research Peptide
Cognitive 10mg

VIP (Vasoactive Intestinal Peptide)

$199.00 In Stock

Neuropeptide for cognitive focus and neuroprotection research.

≥98%
HPLC Purity
COA
Included
USA
Based Supplier

Description

Neuropeptide for cognitive focus and neuroprotection research.

VIP (Vasoactive Intestinal Peptide) is a 28-amino acid neuropeptide belonging to the secretin/glucagon superfamily, originally isolated from porcine duodenum by Said and Mutt in 1970. VIP signals through two G-protein coupled receptors, VPAC1 and VPAC2, both of which activate adenylyl cyclase to elevate intracellular cAMP. Widely distributed throughout the central and peripheral nervous systems, VIP functions as a neurotransmitter and neuromodulator with roles in vasodilation, smooth muscle relaxation, exocrine secretion, circadian rhythm regulation, and neuroprotection. Research by Delgado et al. (2004) in Pharmacological Reviews comprehensively characterized VIP's anti-inflammatory properties, demonstrating suppression of TNF-alpha, IL-6, and IL-12 in activated macrophages while upregulating the anti-inflammatory cytokine IL-10. Studies published in the Journal of Neuroscience by Bhatt et al. showed that VIP protected hippocampal neurons from excitotoxic and oxidative damage through VPAC2-mediated cAMP/PKA signaling. Abad et al. in Annals of the New York Academy of Sciences reported that VIP administration ameliorated experimental autoimmune encephalomyelitis in murine models, suggesting therapeutic potential in neuroinflammatory conditions. Additional research has shown VIP regulates the suprachiasmatic nucleus master clock, influencing circadian output. Compared to PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide), which shares significant structural homology and receptor overlap, VIP has higher selectivity for VPAC receptors and lower affinity for PAC1 receptors. This makes VIP preferred for research specifically targeting VPAC-mediated pathways rather than the broader PAC1-dependent neuroprotective signaling. VIP is sensitive to degradation. Store lyophilized at -20°C. Reconstitute with bacteriostatic water and store at 2-8°C, using within 2-3 weeks. Studied by neuroscientists, immunologists, chronobiologists, and pulmonary researchers investigating airway smooth muscle regulation.

This product is supplied as a lyophilized powder and is intended for laboratory and research use only. Not for human consumption. Each vial contains 10mg of research-grade material.

Research Applications

  • Cognitive focus and neuroprotection
  • Vasodilation and blood flow
  • Immune modulation studies
  • Circadian rhythm regulation

Specifications

Size
10mg
Purity
≥98% (HPLC)
Form
Lyophilized Powder

Storage & Handling

  • Long-term storage: -20°C in a sealed, light-protected container
  • Short-term storage: 2-8°C (refrigerated) for up to 30 days
  • Reconstituted: Store at 2-8°C and use within 30 days
  • Avoid: Repeated freeze-thaw cycles, direct sunlight, and moisture exposure
  • Reconstitution: Use bacteriostatic water or sterile water for injection

Frequently Asked Questions

What is VIP (Vasoactive Intestinal Peptide) and how does it work?
VIP is a 28-amino acid neuropeptide that acts through two G-protein coupled receptors: VPAC1 and VPAC2. It functions as a neurotransmitter and neuromodulator with broad effects including vasodilation, smooth muscle relaxation, immune modulation, and neuroprotection. In the brain, VIP influences circadian rhythm regulation, cortical development, and memory formation. It also modulates immune responses by shifting T-cell differentiation toward anti-inflammatory Th2/Treg profiles.
What research has been done on VIP?
VIP was originally discovered by Said and Mutt (Science, 1970). Research published in the Journal of Immunology demonstrated VIP's anti-inflammatory effects through VPAC receptor activation on immune cells. Studies in Annals of the New York Academy of Sciences explored its neuroprotective properties in Parkinson's disease and Alzheimer's models. Clinical research has investigated intranasal VIP for chronic inflammatory response syndrome (CIRS) and mold-related illness.
How does VIP compare to Semax for neuroprotection?
VIP and Semax are both neuroprotective peptides but work through distinct mechanisms. VIP acts through VPAC1/VPAC2 receptors with broad effects on vasodilation, immune modulation, and circadian regulation. Semax upregulates BDNF through ACTH-derived pathways, enhancing neuroplasticity and cognitive function. VIP has a more diverse receptor profile and broader systemic effects, while Semax is more specifically targeted to neurotrophic factor enhancement.
What is the recommended reconstitution protocol for VIP?
For this 10mg vial, reconstitute with 2mL of bacteriostatic water for a 5mg/mL solution. VIP is a 28-amino acid peptide that dissolves within 3-5 minutes. Add water slowly along the vial wall. VIP can be sensitive to degradation — avoid repeated freeze-thaw cycles. Store reconstituted solution at 2-8°C and use within 14 days.
What purity testing is performed on VIP?
VIP undergoes HPLC purity analysis (minimum 98%), mass spectrometry for molecular weight confirmation, and full 28-amino acid sequence verification. Methionine oxidation is monitored (Met17 oxidation reduces receptor binding). Bioactivity testing through receptor binding assays may be performed. Endotoxin testing, residual solvent analysis, and peptide content determination are included. A COA is provided.

Related Products

Research Use Only. This product is not intended for human consumption, therapeutic use, or diagnostic purposes. All peptides sold by Elyte Peptides are strictly for in-vitro research and laboratory use. By purchasing, you agree to use this product in compliance with all applicable laws and regulations.